Skip to main content
Veterinary Medicines

LIVACOX Q - susp.ad us.vet.

Authorised
  • Eimeria necatrix, Live
  • Eimeria maxima, Live
  • Eimeria acervulina, Live
  • Eimeria tenella, Live

Product identification

Medicine name:
ЛИВАКОКС Q - суспензия за ветеринарномедицинска употреба
LIVACOX Q - susp.ad us.vet.
Active substance:
  • Eimeria necatrix, Live
  • Eimeria maxima, Live
  • Eimeria acervulina, Live
  • Eimeria tenella, Live
Target species:
  • Chicken (layer hen)
  • Chicken
Route of administration:
  • In drinking water use
  • Nebulisation use

Product details

Active substance and strength:
  • Eimeria necatrix, Live
    10000.00
    oocyst(s)
    /
    1.00
    millilitre(s)
  • Eimeria maxima, Live
    30000.00
    oocyst(s)
    /
    1.00
    millilitre(s)
  • Eimeria acervulina, Live
    30000.00
    oocyst(s)
    /
    1.00
    millilitre(s)
  • Eimeria tenella, Live
    30000.00
    oocyst(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • BIOPHARM Vyzkumny ustav biofarmacie a veterinarnich leciv a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biopharm, Research Institute of Biopharmacy and Veterinary Drugs a.s.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1753-03.05.2012
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/02/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 28/02/2022